NCT06333470 is a clinical trial of Primary angle closure diseases in Primary Angle-Closure Glaucoma, sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University.

Who is sponsoring NCT06333470?

NCT06333470 is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University.

What drugs are being tested in NCT06333470?

Interventions in NCT06333470: Primary angle closure diseases.

What condition does NCT06333470 study?

NCT06333470 studies Primary Angle-Closure Glaucoma.

Is NCT06333470 still recruiting?

NCT06333470 is currently status unknown. Last updated 28 March 2024.

Last reviewed 2024-03-28 · How we verify

NCT06333470

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Liwan Eye Study: the Fourth Follow-up

Status unknown Last updated 28 March 2024

What this trial tests

trial testing Primary angle closure diseases in Primary Angle-Closure Glaucoma in 600 participants. Status unknown.

Timeline

30 March 2024

Primary endpoint
30 September 2024

30 September 2024

Quick facts

Lead sponsor	Zhongshan Ophthalmic Center, Sun Yat-sen University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	600
Start date	30 March 2024
Primary completion	30 September 2024
Estimated completion	30 September 2024

Drugs / interventions tested

Primary angle closure diseases

Conditions studied

Primary Angle-Closure Glaucoma — all drugs for Primary Angle-Closure Glaucoma →

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

Adults 70 to 100, any sex, with Primary Angle-Closure Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary angle-closure glaucoma (PACG) is one of the major causes of blindness affecting more than 20 million patients worldwide. The goals of this observational cohort study are to investigate the 20-year incidence of PACG in Chinese population aged 50 years and to develop prediction models for the long-term risk of progression from primary angle-closure suspect (PACS) to PACG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

NCT07524725 — Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on · NA · not yet recruiting
NCT07096622 — Efficacy of Visual and Perceptual Training on Visual Function for Operative Congenital Ectopia Lentis Children · NA · not yet recruiting
NCT06098677 — Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects · NA · not yet recruiting
NCT07512115 — The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surg · NA · not yet recruiting
NCT07512089 — Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06333470 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhongshan Ophthalmic Center, Sun Yat-sen University
Last refreshed: 28 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06333470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing